POLD2 Antibody

What is POLD2 and why is it important in research?

POLD2 is a 469 amino acid protein belonging to the DNA polymerase delta/II small subunit family. It functions as the 50-kDa regulatory subunit of DNA polymerase delta (Pol δ) . POLD2 serves as a critical scaffold for the assembly of Pol δ by interacting simultaneously with all other subunits (p125, p66, and p12) to form a heterotetrameric complex .

POLD2's importance stems from its essential roles in:

• DNA replication fidelity

• Various DNA repair pathways

• Maintenance of genomic stability

• Early embryonic development

Research significance has increased as POLD2 has been implicated in cancer progression, particularly in triple-negative breast cancer and potentially ovarian carcinomas .

What applications are POLD2 antibodies commonly used for?

Methodological consideration: Antibody selection should be guided by the specific experimental application, as not all POLD2 antibodies perform equally across different techniques .

What is the subcellular localization pattern expected when using POLD2 antibodies?

POLD2 primarily localizes to the nucleus, consistent with its function in DNA replication and repair . When performing immunofluorescence studies:

• Expect distinct nuclear staining patterns

• In proliferating cells, POLD2 may show punctate nuclear foci corresponding to replication centers

• Following DNA damage (e.g., UV irradiation or ionizing radiation), POLD2 may relocalize to damage sites, co-localizing with γH2AX

• Upon cell cycle synchronization, subtle changes in localization pattern may be observed

For optimal visualization in IF studies, protocols using paraformaldehyde fixation (4%) followed by permeabilization with Triton X-100 (0.1%) have shown good results .

What are the recommended sample preparation protocols for POLD2 detection?

For Western blotting:

• Total protein extraction using RIPA lysis buffer followed by BCA protein quantification

• Standard reducing conditions with SDS-PAGE (10% gels typically sufficient)

• Expected molecular weight: 51 kDa (calculated), though observed bands may range from 48-52 kDa

For immunohistochemistry:

• Heat-mediated antigen retrieval is critical

• TE buffer pH 9.0 is often recommended, with citrate buffer pH 6.0 as an alternative

• Blocking with 5-10% normal serum (goat or horse) for 30 minutes at room temperature before primary antibody incubation

How can POLD2 antibodies be used to investigate DNA repair mechanisms?

POLD2 antibodies serve as valuable tools for studying DNA repair mechanisms through several sophisticated approaches:

Chromatin Immunoprecipitation (ChIP):
Research has demonstrated successful ChIP protocols using HA-tagged POLD2 followed by qPCR to study its recruitment to double-strand breaks (DSBs). This technique revealed enrichment of POLD2 at sequences flanking DSB sites, with highest concentration within short distances of the break .

Protocol considerations:

• Crosslinking: 1% formaldehyde for 10 minutes at room temperature

• Sonication to generate ~200-500bp fragments

• Immunoprecipitation with anti-HA antibodies for tagged POLD2 or directly with POLD2 antibodies

• qPCR primers should be designed at varying distances from the DSB site to map recruitment patterns

Proximity Ligation Assays (PLA):
PLAs have been successfully employed to visualize POLD2's dynamic interactions with repair proteins. Studies show POLD2 colocalizes with γH2AX following ionizing radiation, though at lower frequencies than 53BP1-γH2AX colocalization .

This methodology provides critical spatial and temporal information about POLD2's role in repair processes that traditional co-immunoprecipitation cannot reveal.

What experimental approaches can reveal POLD2's role in cancer biology?

Studies linking POLD2 to cancer progression, particularly in triple-negative breast cancer (TNBC), employ several methodological approaches:

Gene expression knockdown:

• shRNA-mediated POLD2 knockdown in cancer cell lines (e.g., MDA-MB-231 and SUM-159)

• Confirmation of knockdown efficiency by Western blot and qPCR

• Functional assays including:

  • CCK-8 cell viability assays

  • Colony formation assays

  • EDU incorporation assays for proliferation

Transcriptional regulation analysis:
Research has identified E2F1 as a direct regulator of POLD2 expression in TNBC. Methodological approaches included:

• Chromatin immunoprecipitation to identify transcription factor binding sites

• Luciferase reporter assays with POLD2 promoter constructs

• Site-directed mutagenesis of predicted binding sites

These approaches revealed that the E2F1-POLD2 axis plays a key role in TNBC proliferation, suggesting potential therapeutic targeting strategies .

How can researchers validate the specificity of POLD2 antibodies?

Rigorous validation is essential for ensuring experimental reproducibility and accurate data interpretation. A comprehensive validation strategy includes:

Western blot validation:

• Positive controls: Use cell lines known to express POLD2 (HEK-293T, NIH/3T3, HeLa, Jurkat, SGC-7901, U-251)

• Tissue controls: Mouse colon, mouse pancreas, rat colon tissues have shown reliable positive signals

• Negative controls: POLD2 knockout or knockdown samples

• Molecular weight verification: Expected at ~51 kDa (calculated), though observed at 48-52 kDa

RNA interference controls:

• siRNA or shRNA-mediated knockdown of POLD2

• Compare antibody signal in knockdown vs. control samples across applications (WB/IHC/IF)

• Research has demonstrated successful knockdown protocols in both cell lines and embryonic models

Cross-reactivity consideration:
The existence of a POLD2 pseudogene on chromosome 5 and alternatively spliced isoforms necessitates careful validation to ensure specificity .

What techniques are available for studying POLD2 protein-protein interactions?

Understanding POLD2's interaction network is crucial for elucidating its functions in replication and repair complexes:

Pull-down assays:

• GST-tagged fusion proteins incubated with FLAG-POLD2 have been successful

• Recommended binding buffers contain: 40-mM Tris HCl (pH 7.5), 70-mM NaCl, 0.1-mM DTT, 0.01% NP40, 10% glycerol

• After washing, analyze by SDS-PAGE and immunoblotting

Proximity Ligation Assay (PLA):

• Particularly valuable for studying transient interactions in situ

• Successfully employed to detect POLD2 interactions with Polη following UV irradiation

• Requires primary antibodies against POLD2 and potential interaction partners

• Observed interactions with repair proteins increase following DNA damage

Co-immunoprecipitation:

• Endogenous POLD2 co-immunoprecipitation using optimized lysis conditions

• Antibodies against POLD2 interaction partners (POLD1, PCNA, etc.) can pull down POLD2

• Western blotting with POLD2 antibodies confirms interactions

How does knockout or knockdown of POLD2 affect developmental processes?

Research on POLD2's role in embryonic development has employed sophisticated methodologies:

Genetic knockout approaches:
Studies generated POLD2 knockout mice (C57BL/6N-Pold2tm1.1(KOMP)Vlcg) by inserting a beta-galactosidase containing ZEN-UB1 Velocigene cassette, replacing all coding exons except the first ATG .

Key findings:

• Homozygous POLD2 mutants showed normal morphology at E3.5 blastocyst stage

• Mutants could not be recovered at gastrulation stages

• Outgrowth assays revealed mutant blastocysts could not hatch from zona pellucida

siRNA knockdown methodology:

• Microinjection of POLD2-targeted siRNAs into mouse zygotes

• Cultivation to different developmental stages

• Knockdown efficiency verification by qPCR and immunofluorescence

• This approach successfully recapitulated the knockout phenotype, validating specificity

These experimental approaches highlight POLD2's essential role in early mammalian development and demonstrate complementary genetic and RNAi-based methodologies.

What common challenges arise when using POLD2 antibodies in Western blotting?

Research has shown successful Western blot detection of POLD2 in multiple cell lines including MOLT4, HeLa, Jurkat, K562, C6, Raw264.7, and PC12 .

What are the key considerations for immunohistochemical detection of POLD2?

Successful IHC detection of POLD2 has been reported in multiple tissue types, including:

• Human colon tissue

• Human cervix carcinoma tissue

• Human lung cancer tissue

• Human esophagus cancer tissue

Critical methodological considerations include:

Antigen retrieval optimization:

• Heat-mediated antigen retrieval is essential

• TE buffer pH 9.0 is often recommended as primary choice

• Citrate buffer pH 6.0 serves as an alternative

Antibody dilution optimization:

• Typical working dilutions range from 1:50-1:800

• Tissue-specific optimization may be required

Detection systems:

• HRP-polymer systems for bright-field detection

• Fluorescent secondary antibodies (Alexa Fluor series) for fluorescence detection

• Amplification systems may improve sensitivity for low abundance detection

How can researchers optimize detection of protein-protein interactions involving POLD2?

When investigating POLD2's interactions with other proteins (such as Polη, PCNA, or PIAS2), researchers should consider:

Proximity Ligation Assay optimization:

• Fixation conditions significantly impact results (4% paraformaldehyde recommended)

• Permeabilization requires careful optimization (0.1% Triton X-100 has proven effective)

• Antibody selection is critical - use validated antibodies for both POLD2 and interaction partners

• Include appropriate positive controls (known interactions) and negative controls (non-interacting proteins)

• Quantification should include both percentage of positive cells and number of interaction foci per cell

Co-immunoprecipitation considerations:

• Cell lysis conditions may need optimization to preserve interactions

• Pre-clearing lysates can reduce non-specific binding

• Cross-linking may stabilize transient interactions

• Gentle washing conditions help maintain weak interactions

• Protein elution conditions should be optimized based on interaction strength

Research has shown that POLD2 interactions with repair proteins often increase following DNA damage (UV or IR), suggesting that appropriate treatment conditions should be included in experimental designs .

How might POLD2 antibodies contribute to cancer biomarker research?

Current research suggests POLD2 overexpression correlates with poor prognosis in triple-negative breast cancer and may serve as a marker for ovarian carcinomas . Future research directions could include:

• Development of standardized IHC protocols for POLD2 detection in tumor samples

• Correlation of POLD2 expression with clinical outcomes across cancer types

• Analysis of POLD2 expression in relation to other DNA replication/repair markers

• Exploration of POLD2 as a therapeutic target, with antibodies serving as tools for target validation

Methodological approaches might include:

• Tissue microarray analysis across multiple cancer types

• Multiplex immunofluorescence to co-localize POLD2 with other cancer biomarkers

• Correlation of POLD2 expression with genomic instability markers

• Drug screening assays in POLD2-overexpressing vs. normal cells

What emerging techniques might enhance POLD2 research?

Several cutting-edge methodologies show promise for advancing POLD2 research:

CRISPR/Cas9 genome editing:

• Generation of endogenously tagged POLD2 (e.g., GFP, FLAG) for live-cell imaging

• Domain-specific mutations to dissect functional regions

• Conditional knockout systems for tissue-specific studies

Super-resolution microscopy:

• Nanoscale visualization of POLD2 at replication and repair foci

• Multi-color imaging to map relative positions within protein complexes

• Live-cell super-resolution to track POLD2 dynamics during replication and repair

Mass spectrometry approaches:

• Proximity-dependent biotinylation (BioID, TurboID) to map POLD2 interaction networks

• Phospho-proteomics to identify regulatory post-translational modifications

• Crosslinking mass spectrometry to determine structural interfaces in POLD2 complexes